For all RDRC protocols performed under the authority of 21 CFR 361.1, the RDRC is responsible for ensuring that the studies are approved and conducted in accordance with the applicable FDA regulations. These are protocols for which RDRC-assigned number for the protocol ends with the suffix “F”. For these protocols, the submission of annual and quarterly reports is required.